Rosigitazone Treatment for Fat Redistribution and Metabolic Abnormalities Caused by Anti-HIV Therapy

May 2004
Annals of Internal Medicine;5/18/2004, Vol. 140 Issue 10, pI36
Academic Journal
Presents questions and answers related to the article "Metabolic Effects of Rosiglitazone in HIV Lipodystrophy. A Randomized, Controlled Trial," from the same issue. Study of the possible use of the diabetes drug rosiglitazone to treat or prevent HIV lipodystrophy; Side effects of antiretroviral medications which can cause lipodystrophy; Details of the study; Conclusion that rosiglitazone may help block some of the adverse effects of antiretroviral therapy.


Related Articles

  • Antiretrovirals.  // Reactions Weekly;9/13/2008, Issue 1219, p8 

    The article presents a case study of a 37-year-old man who developed human immunodeficiency virus (HIV)-associated lipodystrophy syndrome while receiving various antiretrovirals for HIV. The patient also developed anaemia during zidovudine therapy, peripheral neuropathy while receiving...

  • Evaluation of Safety and Efficacy of Rosiglitazone in the Treatment of HIV-Associated Lipodystrophy Syndrome. Feldt, T.; Oette, M.; Kroidl, A.; Goebels, K.; Fritzen, R.; Kambergs, J.; Kappert, G.; Vogt, C.; Wettstein, M.; Häussinger, D. // Infection;Apr2006, Vol. 34 Issue 2, p55 

    Background: HIV-associated lipodystrophy syndrome (LDS) as a long-term side effect of HAART is becoming increasingly important and negatively affects adherence to medication. Currently, an effective therapy is not available. There is some evidence that the drug class of thiazolidindiones might...

  • Atazanavir interaction.  // Reactions Weekly;6/24/2006, Issue 1107, p7 

    The article discusses the case of a 66-year-old woman with HIV infection who developed lipodystrophy during antiretroviral treatment with atazanavir and concomitant ritonavir. It references a study by P. Dellamonica, published in the June 2006 issue of the "Journal of Infection." The medical...

  • Perirenal Fat Diameter Measured by Echography Could Be an Early Predictor of Lipodystrophy in HIV Type 1--Infected Patients Receiving Highly Active Antiretroviral Therapy. Asensi, Victor; Martín-Roces, Eustaquio; Carton, José A.; Collazos, Julio; Maradona, José A.; Alonso, Angeles; Medina, Marifé; Aburto, Jesús M.; Martínez, Esteban; Rojo, Carmen; Bustillo, Enrique; Fernández, Cristina; Arribas, José M. // Clinical Infectious Diseases;7/15/2004, Vol. 39 Issue 2, p240 

    Echographically measured thicknesses of perirenal and subcutaneous fat, as well as serum metabolic and anthropometric parameters, were evaluated in 74 human immunodeficiency virus-infected patients receiving highly active antiretroviral therapy (HAART), 22 of whom were HAART-naive at baseline,...

  • Antiretrovirals.  // Reactions Weekly;2/12/2011, Issue 1338, p7 

    The article describes the case of a 43-year-old HIV-positive woman who developed lipodystrophy while receiving antiretroviral treatment.

  • Rapidly growing lipoma as the syndrome of lipodystrophy in HIV-infected child. Mazur-Melewska, Katarzyna; Macedulski, Tomasz; Moryciński, Sebastian; Mania, Anna; Trejster, Ewa; Figlerowicz, Magdalena; Pohland, Justyna; Mańkowski, Przemysław; Służewski, Wojciech // Central European Journal of Medicine;Dec2012, Vol. 7 Issue 6, p753 

    Introduction: Lipomas are benign mesenchymal tumors composed of mature lipocytes grown in different parts of the body. The giant lipomas are very rare in children, however, highly active antiretroviral treatment (HAART) can increase their frequency. Case presentation: We present a case of a...

  • Uridine Metabolism in HIV-1-Infected Patients: Effect of Infection, of Antiretroviral Therapy and of HIV-1/ART-Associated Lipodystrophy Syndrome. Domingo, Pere; Torres-Torronteras, Javier; Pomar, Virginia; Giralt, Marta; Domingo, Joan Carles; Gutierrez, Maria del Mar; Gallego-Escuredo, José M.; Mateo, Maria Gracia; Cano-Soldado, Pedro; Fernandez, Irene; Pastor-Anglada, Marçal; Vidal, Francesc; Villarroya, Francesc; Andreu, Antoni; Marti, Ramon // PLoS ONE;2010, Vol. 5 Issue 11, p1 

    Background: Uridine has been advocated for the treatment of HIV-1/HAART-associated lipodystrophy (HALS), although its metabolism in HIV-1-infected patients is poorly understood. Methods: Plasma uridine concentrations were measured in 35 controls and 221 HIV-1-infected patients and fat uridine in...

  • lipodystrophy syndrome.  // Taber's Cyclopedic Medical Dictionary (2009);2009, Issue 21, p1348 

    A definition of the term "lipodystrophy syndrome," which means a side effect from the treatment of human immunodeficiency virus patients with protease inhibitors, is presented.

  • Antiretrovirals.  // Reactions Weekly;6/27/2009, Issue 1258, p6 

    The article describes the case of a 50-year-old HIV-positive man who experienced lipodystrophy with severe weight gain, dyslipidaemia and obstructive sleep apnoea. The patient received several treatments including cotrimoxazole, indinavir and lamivudine. He reported increased appetite and weight...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics